CPC Main Group
C12Y 117/00 Oxidoreductases acting on CH or CH2 groups (1.17)
Filing statistics
CPC C12Y 117/00 belongs to the parent subclass C12Y, which recorded 144,590 patent applications worldwide between 2013 and 2023. Annual filings grew from 9,773 in 2013 to 11,938 in 2023 (+22%), peaking at 15,970 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).
Source: EPO PATSTAT, worldwide filings
7 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 117/01 with NAD+ or NADP+ as acceptor (1.17.1)
- C12Y 117/02 with a cytochrome as acceptor (1.17.2)
- C12Y 117/03 with oxygen as acceptor (1.17.3)
- C12Y 117/04 with a disulfide as acceptor (1.17.3)
- C12Y 117/05 with a quinone or similar compound as acceptor (1.17.5)
- C12Y 117/07 with an iron-sulfur protein as acceptor (1.17.7)
- C12Y 117/99 with other acceptors (1.17.99)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692